Profile
Scopus profile
Orcid Profile
🎓 Early Academic Pursuits
Dr. Fei Ren began his academic journey in chemistry, earning both B.S. and M.S. degrees from Northwest University between 1993 and 1999. His passion for pharmaceuticals led him to pursue a Ph.D. at the School of Pharmaceutical Sciences, First Military Medical University, completing it in 2004. To broaden his global research perspective, he served as a Visiting Scholar at the University of Memphis in the Department of Chemistry from 2011 to 2012. 🧪📘
💼 Professional Endeavors
Dr. Ren’s career reflects a steady climb through the ranks of pharmacy. He currently serves as the Chief Pharmacist at the Department of Pharmacy, Nanfang Hospital, Southern Medical University—a role he has held since 2015. Prior to this, he was Associate Chief Pharmacist (2008–2015) and Assistant Researcher (2004–2008). His extensive tenure at Nanfang Hospital is a testament to his leadership and deep commitment to clinical and translational pharmaceutical science. 🏥💼
🔬 Contributions and Research Focus On Liposomes
Dr. Ren is a recognized expert in the development of advanced drug delivery systems. His research targets include stimuli-responsive platforms, hybrid biomaterials, cancer therapy, and wound healing applications. Through the integration of photothermal, photodynamic, and enzymatic methods, his work has advanced targeted treatment modalities for breast cancer, melanoma, and diabetic wounds. He has also made notable contributions to the use of metal-organic frameworks (MOFs) in biomedicine. 💊🧫
🌍 Impact and Influence
Dr. Ren’s publications are widely cited in the fields of nanomedicine and biomaterials, influencing the next generation of researchers globally. His high-impact studies appear in journals like ACS Applied Materials & Interfaces, Chemical Engineering Journal, and Journal of Nanobiotechnology. His most cited works on MOF-based nanocarriers, gold nanorods, and stimuli-responsive systems have become critical references for cutting-edge cancer therapy research. 📈🌐
🧠 Research Skills
Dr. Ren exhibits exceptional skills in:
-
Designing multi-functional nanocarriers for targeted therapy
-
Developing stimuli-responsive systems for drug delivery
-
Engineering hybrid biomaterials for regenerative medicine
-
Applying MOFs, gold nanoparticles, and polymeric systems for precise medical applications
-
Leading interdisciplinary projects involving chemistry, biology, and clinical sciences 🔍🧠
🏅 Awards and Honors
Dr. Fei Ren has received numerous accolades for his groundbreaking research:
-
🥉 Third Prize in Science and Technology by the Chinese Pharmaceutical Association (2022)
-
🥇 First Prize for Hospital Pharmacy Science and Technology from the Guangdong Pharmaceutical Association (2021)
In both cases, he was recognized as the first contributor, underscoring his leadership in innovation. 🏆🎖️
🏛️ Legacy and Future Contributions
Dr. Fei Ren’s legacy lies in bridging pharmaceutical innovation with clinical relevance. As a member of the American Chemical Society and Chinese Pharmaceutical Association, and a frequent reviewer for top-tier journals and grant agencies, his expertise continues to shape the research landscape. His future endeavors aim to refine nanomedicine-based cancer treatments and promote biomaterial applications in chronic wound healing. He stands as a pioneer in translational pharmaceutical sciences, inspiring innovation and collaboration. 🌱🔬🚀
Publications Top Notes
📘 ACS Applied Materials & Interfaces (2025)
🔬 Photodynamic Biomimetic Liposomes Targeted to the Endoplasmic Reticulum Enhance Combined Immunotherapy for Triple-Negative Breast Cancer
📘 Archives of Biochemistry and Biophysics (2023)
💊 Metformin ameliorates calcium oxalate crystallization and stone formation by activating the Nrf2/HO‐1 signaling pathway: Two birds with one stone
📘 Chemical Engineering Journal (2020)
🧪 A multifunctional MOF-based nanohybrid as injectable implant platform for drug synergistic oral cancer therapy
📘 Journal of Nanobiotechnology (2019)
🧬 Smart nanoplatform for sequential drug release and enhanced chemo-thermal effect of dual drug loaded gold nanorod vesicles for cancer therapy
📘 MedChemComm (2019)
⚗️ Recent developments on zinc(II) metal–organic framework nanocarriers for physiological pH-responsive drug delivery
📘 Biomaterials Science (2018)
🌡️ Rational design of multi-stimuli-responsive gold nanorod–curcumin conjugates for chemo-photothermal synergistic cancer therapy